Sequential immunotherapy in rare variant renal cell carcinomafinal report of UNISoN (ANZUP 1602): Nivolumab then ipilimumab plus nivolumab in advanced nonclear cell renal cell carcinoma.
JOURNAL OF CLINICAL ONCOLOGY(2022)
关键词
renal cell carcinomafinal,rare variant renal cell,nivolumab,sequential immunotherapy,carcinomafinal report
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要